Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación en Red en Enfermedades Cardiovasculares (21)

2022

  1. Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction

    Scientific Reports, Vol. 12, Núm. 1

  2. Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure

    European Journal of Internal Medicine, Vol. 95, pp. 67-73

  3. Sex-Related Differences in Mortality Following Admission for Acute Heart Failure Across the Left Ventricular Ejection Fraction Spectrum

    Journal of the American Heart Association, Vol. 11, Núm. 1

  4. Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial

    Journal of the American Heart Association, Vol. 11, Núm. 7, pp. e022214

2021

  1. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review

    European Journal of Heart Failure, Vol. 23, Núm. 9, pp. 1445-1457

  2. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure

    European Journal of Internal Medicine, Vol. 92, pp. 94-99

  3. Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure

    Medicina Clinica, Vol. 156, Núm. 12, pp. 589-594

  4. Frailty scales for prognosis assessment of older adult patients after acute myocardial infarction

    Journal of Clinical Medicine, Vol. 10, Núm. 18

  5. Iron deficiency and short-term adverse events in patients with decompensated heart failure

    Clinical Research in Cardiology, Vol. 110, Núm. 8, pp. 1292-1298

  6. Matrix metalloproteinase-12 cleaved fragment of titin as a predictor of functional capacity in patients with heart failure and preserved ejection fraction

    Scandinavian Cardiovascular Journal, Vol. 55, Núm. 1, pp. 9-14

  7. Right Heart Dysfunction and Readmission Risk Across Left Ventricular Ejection Fraction Status in Patients With Acute Heart Failure

    Journal of Cardiac Failure, Vol. 27, Núm. 10, pp. 1090-1098

2020

  1. Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial)

    Clinical Cardiology, Vol. 43, Núm. 5, pp. 423-429

  2. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

    American Journal of Medicine, Vol. 133, Núm. 3, pp. 370-380.e4

  3. Chronotropic Incompetence Predicts Distance Walked in Six-Minute Walk Test in Heart Failure With Preserved Ejection Fraction

    Journal of Cardiac Failure

  4. Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 463-470

  5. Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure

    ESC Heart Failure, Vol. 7, Núm. 6, pp. 3320-3328

  6. Exercise-based cardiac rehabilitation: an underused approach for management of heart failure patients

    REC: CardioClinics, Vol. 55, Núm. 4, pp. 204-206

  7. Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial

    ESC Heart Failure, Vol. 7, Núm. 6, pp. 4222-4230

2019

  1. Early Sacubitril/Valsartan-driven Benefit on Exercise Capacity in Heart Failure With Reduced Ejection Fraction: A Pilot Study

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 167-169

2018

  1. Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study

    Clinical Cardiology, Vol. 41, Núm. 4, pp. 476-480